Aastrom Biosciences, Inc. to Present at 2011 Biotechnology Industry Organization (BIO) CEO & Investor Conference

ANN ARBOR, Mich., Feb. 11, 2011 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will speak at the 13th Annual BIO CEO & Investor Conference in the Park South wing of the Waldorf-Astoria Hotel on February 15 from 10:00-10:25 AM ET.

MORE ON THIS TOPIC